Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Viibryd- New Antidepressant approved by FDA recently
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Viibryd- New Antidepressant approved by FDA recently
Admin Wed Jul 27, 2011 5:39 pm
FDA approves Viibryd to treat major depressive disorder
The U.S. Food and Drug Administration approved Viibryd tablets (vilazodone hydrochloride) to treat major depressive disorder in adults (Jan. 21, 2011).
The most frequent adverse reactions reported by patients taking Viibryd in clinical trials included diarrhea, nausea, vomiting, and insomnia.
The drug will be available in 10, 20 and 40 milligram tablets.
Viibryd and all other antidepressant drugs have a boxed warning and a patient medication guide describing the increased risk of suicidal thinking and behavior in children, adolescents, and young adults ages 18 to 24 during initial treatment. The warning also says data did not show this increased risk in adults older than 24 and that patients ages 65 and older who take antidepressants have a decreased risk of suicidal thinking and behavior. The warning says depression and other serious psychiatric disorders themselves are the most important causes of suicide and that close monitoring of patients starting these medications is necessary.
For more details: FDA (Food and Drug Administration)
Please share your experience of Viibryd use (dose, indication, side effect, etc).
Thanks
The U.S. Food and Drug Administration approved Viibryd tablets (vilazodone hydrochloride) to treat major depressive disorder in adults (Jan. 21, 2011).
The most frequent adverse reactions reported by patients taking Viibryd in clinical trials included diarrhea, nausea, vomiting, and insomnia.
The drug will be available in 10, 20 and 40 milligram tablets.
Viibryd and all other antidepressant drugs have a boxed warning and a patient medication guide describing the increased risk of suicidal thinking and behavior in children, adolescents, and young adults ages 18 to 24 during initial treatment. The warning also says data did not show this increased risk in adults older than 24 and that patients ages 65 and older who take antidepressants have a decreased risk of suicidal thinking and behavior. The warning says depression and other serious psychiatric disorders themselves are the most important causes of suicide and that close monitoring of patients starting these medications is necessary.
For more details: FDA (Food and Drug Administration)
Please share your experience of Viibryd use (dose, indication, side effect, etc).
Thanks
Admin- Admin
- Posts : 948
Points : 2102
Reputation : 0
Join date : 2011-02-19
Location : Philadelphia -
Similar topics» New SNRI Approved by FDA: Levomilnacipran
» Lisdexamfetamine Dimesylate: Only Stimulant Approved by FDA for ADHD Maintenance.
» Q- Which of these medications are FDA Approved for treatment of Alcohol Dependence?
» FDA Approved Medication for 10 yr old Bipolar Disorder patient?
» An Update on Antidepressant Use in Bipolar Depression
» Lisdexamfetamine Dimesylate: Only Stimulant Approved by FDA for ADHD Maintenance.
» Q- Which of these medications are FDA Approved for treatment of Alcohol Dependence?
» FDA Approved Medication for 10 yr old Bipolar Disorder patient?
» An Update on Antidepressant Use in Bipolar Depression
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
» L-Methylfolate: Who Will benefit
» Vitamins & Supplements in Clinical Practice.
» Imaging Biomarkers for Outcomes in Mild TBI
» Q.5 Clozapine Neutopenia
» Treating Disorders!
» Cortical Abnormalities in Adults & Adolescents with MDD
» Efficacy of Antipsychotics in Pediatric Acute Mania
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?